Unicycive Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2020 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Unicycive Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2020 to Q3 2024.
  • Unicycive Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 97.9M shares, a 182% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 97.9M +63.1M +182% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 43.6M +28.3M +186% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 37.6M +22.4M +147% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 34.8M +19.5M +128% Dec 31, 2023 10-Q 2024-11-13
Q3 2023 34.8M +19.7M +130% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 15.2M +192K +1.27% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 15.2M +213K +1.42% Mar 31, 2023 10-Q 2023-05-16
Q4 2022 15.2M +235K +1.57% Dec 31, 2022 10-K 2024-03-28
Q3 2022 15.1M +115K +0.77% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 15M +6.27M +71.5% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 15M Mar 31, 2022 10-Q 2022-05-12
Q4 2021 15M +6.48M +76.1% Dec 31, 2021 10-K 2023-03-31
Q3 2021 15M Sep 30, 2021 10-Q 2021-11-12
Q2 2021 8.77M Jun 30, 2021 10-Q 2021-08-16
Q4 2020 8.51M Dec 31, 2020 10-K 2022-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.